Gallbladder Adenocarcinoma
Symptoms, Doctors, Treatments, Advances & More

Gallbladder Adenocarcinoma Overview

Save information for later
Sign Up

Learn About Gallbladder Adenocarcinoma

View Main Condition: Gallbladder Cancer

What is the definition of Gallbladder Adenocarcinoma?
Gallbladder adenocarcinoma is a type of cancer that starts in gland-like cells that line the gallbladder. The gallbladder is a small pear-shaped organ below the liver that stores bile, which is a digestive fluid.
What are the symptoms of Gallbladder Adenocarcinoma?
Gallbladder adenocarcinoma may not have any symptoms until the late stages of the disease. Symptoms of gallbladder adenocarcinoma may include nausea and vomiting, loss of appetite, fever, abdominal bloating, abdominal pain in the right upper side, abdominal lumps, unexplained weight loss, itchy skin, dark urine, pale or greasy stools, and yellowing of the whites of the eyes and skin.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Gallbladder Adenocarcinoma?
Treatment for gallbladder adenocarcinoma depends on the stage, or how far it has progressed. Treatments for gallbladder adenocarcinoma include surgery, chemotherapy, radiation therapy, targeted drug therapy, and immunotherapy.
Who are the top Gallbladder Adenocarcinoma Local Doctors?
Elite in Gallbladder Adenocarcinoma
Dr. Timothy M. Pawlik
Surgical Oncology
Elite in Gallbladder Adenocarcinoma
Dr. Timothy M. Pawlik
Surgical Oncology
Referral may be required

Ohio State Martha Morehouse Outpatient Care

2050 Kenny Rd, 
Columbus, OH 
614-293-3890
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Pawlik is a Surgical Oncologist practicing medicine in Columbus, Ohio. Dr. Pawlik is rated as an Elite provider by MediFind in the treatment of Gallbladder Adenocarcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy. Dr. Pawlik is currently accepting new patients.

Elite in Gallbladder Adenocarcinoma
Elite in Gallbladder Adenocarcinoma
Referral may be required

Banner-University Medical Center Tucson Campus

1625 North Campbell Avenue, 
Tucson, AZ 
520-694-0111
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Rachna Shroff is an Oncologist practicing medicine in Tucson, Arizona. Dr. Shroff is rated as an Elite provider by MediFind in the treatment of Gallbladder Adenocarcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Gallbladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Shroff is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Shroff is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Gallbladder Adenocarcinoma
Dr. Laleh G. Melstrom
General Surgery | Surgical Oncology
Distinguished in Gallbladder Adenocarcinoma
Dr. Laleh G. Melstrom
General Surgery | Surgical Oncology
Referral may be required

City Of Hope Comprehensive Cancer Center-Duarte

1500 Duarte Rd, 
Duarte, CA 
888-304-3959
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Laleh Melstrom is a General Surgeon and a Surgical Oncologist practicing medicine in Duarte, California. Dr. Melstrom is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Adenocarcinoma. She is also highly rated in 45 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Hepatectomy.

View All Doctors
What are the latest Gallbladder Adenocarcinoma Clinical Trials?
Phase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Phase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Enrollment Status: Recruiting
Publish Date: September 08, 2026
Intervention Type: Diagnostic test, Procedure
Study Phase: Phase 2

Summary: This is a randomized, open label, single-center, phase 2, randomized controlled trial of sequential cytoreductive intervention versus standard of care therapy for patients with intervenable oligometastatic (stage IV) cancer of the upper gastrointestinal (GI) tract and undetectable ctDNA at the time of randomization after a three-month induction chemotherapy period.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Enrollment Status: Recruiting
Publish Date: April 20, 2026
Intervention Type: Drug
Study Phase: Early Phase 1

Summary: Gallbladder adenocarcinoma is a devastating disease associated with a poor prognosis. Gallbladder and other biliary cancers will be responsible for an estimated 11,980 new cases, and 4,090 deaths in the US during 2020. The 5-year survival for all patients with gallbladder cancer is 18%, however this plummets to 2% for patients with metastatic disease. Patients with gallbladder cancer frequently de...

View All Clinical Trials